SOURCE: Bio-Rad Laboratories

September 04, 2012 09:00 ET

Bio-Rad's Tour de Cure National Team Raises Over $112,000

HERCULES, CA--(Marketwire - Sep 4, 2012) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products for the first time participated as an official National Team for Tour de Cure and raised over $112,000 in the organization's cycling events that took place this year to benefit the American Diabetes Association.

Bio-Rad's National Team took part in several Tour de Cure events so far this year having its largest presence of nearly 200 riders at the Napa Valley Tour de Cure that occurred in May. As a National Team, all donations raised by Team Bio-Rad at different Tour de Cure events throughout the year are counted together to obtain one grand total. 

"As long standing supporters of Tour de Cure, we were honored to participate as a National Team this year," said Bio-Rad President and CEO Norman Schwartz. "It is wonderful to see the interest and support of all of the participants in making Tour de Cure such a success.
By supporting events such as Tour de Cure, we are helping to improve the lives of those suffering from diabetes," he said.

About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 100,000 research and industry customers worldwide through its global network of operations. The company employs over 7,100 people globally and had revenues exceeding $2 billion in 2011. For more information, visit

Contact Information

  • For more information, please contact:
    Bio-Rad Laboratories, Inc.
    Tina Cuccia
    Corporate Communications
    Email Contact